Learn more

BOEHRINGER INGELHEIM ITALIA

Overview
  • Total Patents
    192
About

BOEHRINGER INGELHEIM ITALIA has a total of 192 patent applications. Its first patent ever was published in 1987. It filed its patents most often in Italy, Australia and Norway. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and micro-structure and nano-technology are CGI PHARMACEUTICALS INC, EPIGEN BIOSCIENCES INC and VANTIA LTD.

Patent filings per year

Chart showing BOEHRINGER INGELHEIM ITALIAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Turconi Marco 100
#2 Cereda Enzo 67
#3 Bignotti Maura 48
#4 Borsini Franco 44
#5 Schiavi Giovanni Battista 39
#6 Sagrada Angelo 39
#7 Giraldo Ettore 36
#8 Maffione Grazia 35
#9 Martino Vincenzo 32
#10 Dubini Enrica 30

Latest patents

Publication Filing date Title
AU7653700A New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity
CN1178524A Di-substituted 1, 4 -piperidine esters and amides having 5-HT4 antagonistic activity
AU5101096A Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity
US5552408A Benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
EP0694033A1 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
AU5627194A New use of 5-ht3 receptor antagonists
IL106119D0 Azacyclic and azabicyclic alkylidene hydroxylamines,their preparation and pharmaceutical compositions containing them
WO9402177A1 Method of preparation of inclusion compounds of nimesulide with cyclodextrins
AU4325393A Azacyclic and azabicyclic hydroxylamines as muscarinic receptor agonists
PH30413A Crystalline forms of endo-2,3-dihydro-n-(8-methyl)-8-azabicyclo-(3,2,1)oct-3-yl)-2-oxo-1h-benzimidazole-1-carboxamides
IL102381D0 Pharmaceutical compositions containing benzimidazoline-2-oxo-1-carboxylic acid derivatives for the treatment of organic mental diseases
ITMI921005A1 Optically active derivatives of N-iminoalkyl-N'-[(2- hydroxy-2-phenyl-2-cyclohexyl)-ethyl]-piperazine
ITMI920723D0 Crystalline form of endo-2,3-dihydro-N-(8-methyl-8- azabicyclo-[3.2.1]oct-3-yl)-2-oxo-1H-benzimidazole-1- carboxamide hydrochloride
ITMI920720D0 Crystalline form of endo-3-ethyl-2,3-dihydro-N-(8-methyl- 8-azabicyclo[3.2.1]oct-3-yl)-2-oxo-1H-benzimidazole-1- carboxamide hydrochloride
US5223511A Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists
ITMI912874D0 Inclusion compounds of meloxicam with cyclodextrin
ITMI912118D0 BENZIMIDAZOLONE DERIVATIVES
KR100198046B1 Inclusion compounds of nimesulide with cyclodextrins, process for preparation thereof and pharmaceutical composition containing the same
PL285669A1 Method for manufacturing new derivatives of t(-) 3-chinuclidinol
CZ33590A3 Novel nitrogen-containing heterocyclic derivatives